for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Brazil authorizes import of raw material to produce Chinese COVID-19 vaccine

BRASILIA, Oct 28 (Reuters) - Brazil’s health regulator Anvisa said on Wednesday it has authorized the import of raw materials from Chinese company Sinovac for the production of its COVID-19 vaccine.

Sao Paulo’s biomedical institute Butantan plans to produce the vaccine. (Reporting by Ricardo Brito, writing by Stephen Eisenhammer, editing by Chris Reese)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up